Pharmacokinetics and bioequivalence of topiramate tablets in healthy volunteers

ZHAO Rong-sheng,HUANG Jing,YANG Li
2005-01-01
Abstract:Objective To study the pharmacokinetic characteristics of topiramate tablets in healthy volunteers, compare the bioequivalence of two topiramate tablets. Methods A single oral dose 100 mg of tested and referenced topiramate tablets were given to 18 healthy volunteers in a randomized cross - over. The gas chromatography with nitrogen phosphorus detection method was used to assay the concentration of topiramate in plasma. The pharmacokinetic parameters and bioequivalence were measured. Results The main pharmacokinetic parameters of topiramate by oral administration were as follow:Cmax were (2. 05 ± 0. 45) and (1. 97 ± 0. 43)μg·mL-1, tmax were(1. 14 ±0. 68)and(1. 28 ±0.60) h,t1/2 were(30. 19 ±5.01)and (31.07±4.67) h, AUC0-t were(52.00 ±8. 84) and(52. 88 ±9. 84)μg ·h·mL-1, AUC0-∞ were(65. 74 ± 14. 34) and(67. 62 ± 14. 22)μg·h ·mL-1 for test and reference topiramate tablets, respectively. The relative bioavailability F0-t, and F0-∞ were (99. 12 ± 10.50)% and (97.65 ± 10. 96) % , respectively. Conclusion The test and reference topiramate tablets are bioequivalence.
What problem does this paper attempt to address?